Abstract-Background: Atherosclerosis may be linked to cognitive decline and depression in old age. Methods: The Leiden 85-Plus Study is a prospective population-based study of 599 subjects from age 85 onward. The generalized atherosclerotic burden was rated by the number of cardiovascular pathologies at baseline, as assessed by history taking from treating physicians and EKG. Cardiovascular pathologies included myocardial infarction, angina pectoris or myocardial ischemia, claudicatio intermittens, and arterial surgery. Global cognitive function (Mini-Mental State Examination), attention (Stroop Test), processing speed (Letter Digit Coding Test), immediate recall memory (Word Learning TestImmediate Recall), delayed recall memory (Word Learning Test-Delayed Recall), and depressive symptoms (15-item Geriatric Depression Scale) were assessed each year from ages 85 through 90. The prospective associations between both the generalized atherosclerosis rating and stroke with cognitive function and depressive symptoms were analyzed by linear mixed models adjusted for sex and level of education. Results: During follow-up, there was a significant cognitive decline and a significant increase of depressive symptoms. At baseline, a history of stroke was correlated with lower global cognitive function, slower processing speed, impaired immediate and delayed recall memory, and more depressive symptoms. In addition, a higher generalized atherosclerosis rating was correlated with impaired global cognitive function, lower attention, and a slower processing speed at baseline. During follow-up, a higher generalized atherosclerosis rating was associated with an accelerated decline of immediate recall memory and delayed recall memory. In contrast, there was no relation between the generalized atherosclerosis rating and depressive symptoms, either in the cross-sectional analysis or in the prospective analysis. Conclusion: In the population at large, generalized atherosclerosis contributes to cognitive decline in old age but not to depression.
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Emerging evidence suggests a causal relationship between atherosclerosis and both cognitive decline and depression in old age. [1] [2] [3] [4] Among others, enlarged intima-media thickness and presence of carotid artery plaques have been associated with an increased prevalence of both dementia and depression. [4] [5] [6] Moreover, neuropathologic findings indicate that subjects with cognitive impairment more often have vascular pathology, 7, 8 whereas late-life depression has been associated with white matter hyperintensities on MRI of the brain, which are assumed to have a vascular origin. [9] [10] [11] [12] Various methodologic issues hamper causal inference of the data so far. First, signs and symptoms of cognitive decline in old age are difficult to distinguish from depression. 13, 14 As such, it is unclear whether they are different outcomes of the same disease process, have similar risk factors, or result from each other. Second, most studies on the topic have used a crosssectional design, which limits causal inference. [4] [5] [6] 15 Third, the impact of atherosclerosis on cognitive decline and depression has not been examined simultaneously to disentangle the various relations. 16 We had the unique opportunity to study the impact of generalized atherosclerosis on cognitive decline and depressive symptoms within the Leiden 85-Plus Study. We followed 599 community-dwelling elderly people from ages 85 through 90 with annual assessments of various cognitive domains and depressive symptoms and determined the impact of generalized atherosclerosis and stroke at baseline on these outcomes.
Methods. The Leiden 85-Plus Study is a prospective populationbased study of all 85-year-old inhabitants of Leiden, the Netherlands. Between September 1, 1997, and September 1, 1999, 599 subjects were enrolled (response 87%). 17 Subjects were visited annually from ages 85 through 90 at their homes for face-to-face interviews. The Medical Ethical Committee of the Leiden University Medical Center approved the study, and all subjects gave informed consent to participate. Atherosclerosis, cognitive function, and depressive symptoms have special emphasis within the Leiden 85-Plus Study.
17 Figure 1 shows the annual follow-up visits of 599 participants from ages 85 through 90 within the Leiden 85-Plus Study. During 1,954 person-years of follow-up (mean per person, 3.3 years), 44 subjects (7%) declined to participate in the repeated measurements, most of the refusals concerning the first follow-up visit.
The burden of generalized atherosclerosis was rated by the number of cardiovascular pathologies at baseline, as assessed by history taking from treating physicians and EKG. Cardiovascular pathologies included 1) myocardial infarction, 2) angina pectoris or myocardial ischemia, 3) claudicatio intermittens, and 4) arterial surgery. Treating physicians of all subjects were interviewed to assess the medical history of myocardial infarction, angina pectoris, claudicatio intermittens, and arterial surgery. For all participants, EKGs were recorded on a Siemens Siccard 440 (Erlangen, Germany) and transmitted electronically to the EKG Core Laboratory in Glasgow for automated Minnesota coding. 18 Myocardial infarction was assessed by Minnesota codes 1-1, 1-2, and 1-3 and myocardial ischemia by Minnesota codes 4-1, 4-2, 4-3, 5-1, 5-2, and 5-3. This approximation for the burden of generalized atherosclerosis follows the classification from the Second Manifestation of ARTerial Disease Study, which showed that the number of cardiovascular pathologies is related to the severity of atherosclerosis measured as intima-media thickness and arterial stiffness. 19 The presence of stroke in medical history was assessed by interviewing treating physicians of all subjects.
Global cognitive functioning was assessed with the MiniMental State Examination (MMSE). 20 Possible scores on the MMSE range from 0 to 30 points, with lower scores indicating impaired global cognitive functioning. Attention was measured using the third chart of the 40-item Stroop Test. Outcome was the time needed to name the ink color of the 40 incongruous printed names of colors. Higher scores indicated worse attention. Processing speed was assessed with the Letter Digit Coding Test. Outcome was the total number of correct digits according to a code key in 60 seconds. Lower scores indicated a slower speed. Immediate and delayed recall memory were determined with the 12-Word Learning Test. In this test, 12 pictures were presented, and the subject was asked to recall the presented pictures. This procedure was carried out three times. After 20 minutes, the participants were asked to recall the presented pictures again. Outcome for the immediate recall memory was the total number of correct recalled pictures during the three procedures, and possible scores ranged from 0 to 36 pictures. Outcome for the delayed recall memory was the total number of correct recalled pictures after 20 minutes, and possible scores ranged from 0 to 12 pictures. Lower scores indicated an impaired memory. Parallel versions for the coding and memory tests, using identical procedures but with different items, were available to prevent learning effects.
These five neuropsychological tests have been proven to be sensitive to detect small differences in elderly subjects. 21 Global cognitive function was assessed in all participants. Attention, processing speed, and immediate and delayed recall memory were not administered in subjects with an MMSE score below 19 points because of a lack of reliability and validity of these tests in subjects with severe cognitive impairment. The percentage of participants with a MMSE score of 18 points or lower increased from 17% at age 85 (n ϭ 99) to 27% (n ϭ 75) at age 90.
Depressive symptoms were annually assessed with the 15-item Geriatric Depression Scale (GDS-15), a questionnaire developed as a screening instrument for depressive symptoms in elderly populations. 22 The use of the GDS-15 to detect depression has been validated within the Leiden 85-Plus Study. 23 In addition, we have shown earlier that the GDS-15 is able to ascertain longitudinal alterations in depressive symptoms. 24 Because of a lack of reliability and validity in cognitively impaired subjects, the GDS-15 was not administered to subjects with an MMSE score below 19 points.
Sociodemographic characteristics were obtained for all subjects. The level of education was dichotomized at 6 years of schooling. Chronic diseases, including diabetes mellitus, chronic obstructive pulmonary disease (COPD), arthritis, malignancy, and Parkinson disease (PD), were assessed by interview of the treating physician of each participant using structured questionnaires. Furthermore, computerized pharmacy registries were checked for use of medication specific for the presence of diabetes mellitus, COPD, or PD. Moreover, diabetes mellitus was also considered present for subjects with nonfasting blood glucose levels of Ն11.0 mmol/L.
Baseline data are presented as medians and interquartile ranges (IQRs). The associations between the generalized atherosclerosis rating at baseline and the course of cognitive function and depressive symptoms during follow up were analyzed with linear mixed models. Mixed models use all available data during follow-up, properly account for correlation between repeated measurements, and appropriately handle missing data. They also allow for the use of time-independent and time-dependent covariates. The flexibility of mixed models makes them the preferred choice for the analysis of repeated-measures data. 25 The used models included the generalized atherosclerotic rating at baseline, history of stroke, time, and the interaction of time and the generalized atherosclerotic rating at baseline. The estimates for "cardiovascular rating at baseline" and "history of stroke" reflect the cross-sectional impact on cognitive function and depressive symptoms. The estimate for "time" reflects the annual change of cognitive function and depressive symptoms for those with a cardiovascular rating of 0 points. The estimate for "time by generalized atherosclerotic rating at baseline" reflects the additional annual effect of each extra point of the generalized atherosclerotic rating on the change of cognitive function or depressive symptoms during follow-up. All models were adjusted for sex and level of education. Furthermore, models with cognitive scores as dependent variable were adjusted for the GDS-15 score, and models with depressive symptoms as dependent variable were adjusted for the MMSE, by entering the variables as time-dependent covariates into the models. In an additional analysis, the courses of both cognitive function and depressive symptoms were adjusted for the number of chronic diseases.
Results. Table 1 presents the sociodemographic and clinical characteristics of all 599 participants at baseline. In total, 202 subjects (34%) were men, and 386 subjects (64%) had a low level of education. At baseline, the median number of cardiovascular pathologies was one (IQR 0 to 1), 239 subjects (40%) had no cardiovascular pathologies, and 357 subjects (60%) had one or more cardiovascular pathologies. In addition, 62 participants (10%) had a medical history of stroke. The median MMSE score at baseline was 26 points (IQR 22 to 28 points), whereas the median GDS-15 score at baseline was 2 points (IQR 1 to 3 points). Figure 2 presents the cognitive function and depressive symptoms from ages 85 through 90 as estimated from the linear mixed models adjusted for sex and level of education. During follow-up, there was a decline in all cognitive domains and an increase of depressive symptoms (all p Ͻ 0.001). Table 2 shows the impact of stroke and generalized atherosclerosis on cognitive function and depressive symptoms from age 85 onward. At baseline, the presence of stroke was associated with lower baseline MMSE scores (Ϫ1.4 points; p ϭ 0.001), lower scores on the Word Learn- ing Test-Immediate Recall (Ϫ2.0 words; p ϭ 0.05), lower scores on the Word Learning Test-Delayed Recall (Ϫ1.0 words; p ϭ 0.03), and higher scores on the GDS-15 (0.83 point; p ϭ 0.04). In addition, a higher generalized atherosclerosis rating was at baseline associated with a lower MMSE score (Ϫ0.27 point per cardiovascular pathology; p ϭ 0.05), a slower Stroop Test (4.9 seconds per cardiovascular pathology; p ϭ 0.002), and a lower Letter Digit Coding Test score (Ϫ0.69 digit per cardiovascular pathology; p ϭ 0.04). There was no association between generalized atherosclerosis and depressive symptoms at baseline (Ϫ0.08 point; p ϭ 0.54). After adjustment for chronic diseases, the baseline estimates remained materially unchanged (data not shown).
During follow-up, generalized atherosclerosis was associated with an accelerated decline of the Word Learning Test-Immediate Recall (see table 2; Ϫ0.13 word per year per cardiovascular pathology; p ϭ 0.03) and an accelerated decline of the Word Learning Test-Delayed Recall (Ϫ0.05 word per year per cardiovascular pathology; p ϭ 0.04). These estimates remained materially unchanged after adjustment for chronic diseases (data not shown). There was no association between the generalized atherosclerosis rating and GDS-15 scores over time (Ϫ0.04 point per year per cardiovascular pathology; p ϭ 0.17).
Discussion. This prospective population-based study shows that in old age, generalized atherosclerosis is related to cognitive decline, especially to decline of memory function. Previous prospective studies have reported that signs of systemic atherosclerotic disease are associated with global cognitive decline in elderly subjects. [26] [27] [28] However, inference of these findings is hampered by the frequent cooccurrence of depressive symptoms that have an effect on performance on the cognitive function tests. 13, 14 In contrast, we found no association between generalized atherosclerosis and the occurrence of depressive symptoms. This latter finding should be interpreted in the light that several other studies have shown that the relation between cardiovascular disease and late-life depression is attenuated after adjustment for functional disability. 10, 12, [29] [30] [31] In the current study, we found that the relation between generalized atherosclerosis and cognitive decline is not distorted by co-occurrence of depressive symptoms, history of stroke, or presence of chronic diseases. This is important because in old age, signs and symptoms of cognitive impairment and depressive symptoms overlap substantially. Hence, it is often unclear whether cognitive impairment and depressive symptoms are different outcomes of the same disease process, have similar risk factors, or just often co-occur. 32, 33 Earlier, we reported that these depressive symptoms in themselves were not predictive of cognitive decline, whereas cognitive impairment preceded depressive symptoms. 34 Accumulating evidence emerges that generalized atherosclerosis plays a pivotal role in the etiology of dementia. 1, 2, 7, 8 Perhaps the strongest argument is that treatment of risk factors for atherosclerosis, such as hypertension, may prevent dementia, 35 although this has not been shown unequivocally. 36 Several plausible mechanisms that underlie the relation between atherosclerosis and cognitive impairment have been hypothesized, including ischemic lesions affecting the critical neuronal networks and ischemia triggering an inflammatory host response leading to neuronal degeneration. 2, 37 In contrast to general expectation, we found that generalized atherosclerosis was not a risk factor for depressive symptoms in our study population. This finding argues against the vascular depression hypothesis. 3 Data in support of the vascular depression hypothesis come mainly from neuroimaging studies in patients with late-life depression. In these studies, patients with late-life depression had more white matter hyperintensities than age-matched control subjects. [9] [10] [11] [12] When findings on autopsy and those on MRI are compared, the white matter hyperintensities of patients with late-life depression more often have an ischemic origin compared with nondepressed elderly control subjects. 38 It is remarkable, however, that these white matter hyperintensities are not associated with atheromatous disease. 39 In contrast to the neuroimaging studies, the clini- Arterial surgery 40 (7) Claudicatio intermittens 37 (6) No. of cardiovascular pathologies (range) † § 1 (0-1)
History of stroke, n (%) 62 (10) Cognitive function cal data that support a relation between cardiovascular disease and depression are more difficult to interpret. Some consider the occurrence of depression in patients after a myocardial infarction as an argument in favor of the vascular depression hypothesis. 40 However, this relation has been shown to be nonspecific, 41 and other pathologies such as disability, stress, and medication might provide an alternative explanation for the occurrence of depression in these patients. 42 Final proof will come from specific intervention studies that are currently under way. 43 Is it possible that in old age, generalized atherosclerosis is related to cognitive decline but not to depressive symptoms, whereas ischemia is found in both dementia and depression? The ischemic lesions in the brain are generally thought of as being linear, with the atherosclerotic obstructions in the arteries that supply it. This reasoning may not necessarily be true. For instance, the pathogenesis of obstructions in the long perforating arterioles that directly sprout from the cerebral arteries is different from atherosclerosis. These obstructions have been described as "hyaline degeneration" and have, at least in part, different risk factors than atherosclerosis. 44, 45 Second, different from considering critical obstructions only, ischemic lesions in the brain can also be a result of low tissue perfusion. Indeed, the presence of obstructions in arteries and arterioles jeopardizes flow. However, flow is principally determined by blood pressure, which is related to cardiac function. Finally, ischemia in the brain may occur from low oxygenation despite sufficient flow. Hypoxia due to hypoventilation may account for such a phenomenon. 46 Taken together, it can therefore be hypothesized that the different risk factors lead to different pathologies in the brain with variable signs and symptoms, whereas in old people, these various mechanisms are likely to co-occur.
Strengths of the current study are the populationbased sample of the oldest old with a high incidence of cognitive decline and depression, the annual repeated assessments of various cognitive domains and depressive symptoms, the quantitative assessment of the burden of generalized atherosclerosis at baseline, the distinction between atherosclerosis and stroke during analyses, and the use of linear mixed models that allow optimal use of the data. A limitation of the study is that we were unable to obtain data on vascular imaging to assess the extent of generalized atherosclerosis more precisely. It must, however, be emphasized that the number of cardiovascular pathologies has been shown to be closely related with intima-media thickness and arterial stiffness of the carotid artery, 19 demonstrating the generalized nature of the disease. Another limitation is that dementia and depression were not formally diagnosed, but it becomes increasingly clear that both dementia and depression may better be interpreted as a continuum of symptoms rather than the mere presence or absence of a disease. 47 When assessed on a continuous scale, as it is presented here, both the early and the late stages of the diseases are included in the analyses, and this is likely to add to the power of the study to find significant associations. Associations were assessed by linear mixed models adjusted for sex and level of education. Cognitive dependents were adjusted for the 15-item Geriatric Depression Scale, and depressive symptoms were adjusted for the Mini-Mental State Examination. The effect of generalized atherosclerosis was expressed per cardiovascular pathology extra. Stroke is not included in generalized atherosclerosis rating.
